Direkt zum Inhalt
Merck
  • Tetrapentylammonium block of chloramine-T and veratridine modified rat brain type IIA sodium channels.

Tetrapentylammonium block of chloramine-T and veratridine modified rat brain type IIA sodium channels.

British journal of pharmacology (2001-04-20)
A S Ghatpande, S Rao, S K Sikdar
ZUSAMMENFASSUNG

Tetrapentylammonium (TPeA) block of rat brain type IIA sodium channel alpha subunit was studied using whole cell patch clamp. Results indicate that TPeA blocks the inactivating brain sodium channel in a potential and use-dependent manner similar to that of the cardiac sodium channel. Removal of inactivation using chloramine-T (CT) unmasks a time-dependent block by TPeA consistent with slow blocking kinetics. On the other hand, no time dependence is observed when inactivation is abolished by modification with veratridine. TPeA does not bind in a potential-dependent fashion to veratridine-modified channels and does not significantly affect gating of veratridine-modified channels suggesting that high affinity binding of TPeA to the brain sodium channel is lost after veratridine modification.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Tetrapentylammoniumbromid, ≥99%
Sigma-Aldrich
Tetrapentylammoniumhydroxid -Lösung, ~20% in H2O (T)
Supelco
Tetrapentylammoniumbromid, suitable for ion pair chromatography, LiChropur, ≥99.0% (AT)